300676 華大基因
按盤價 
49.610 +0.420 (+0.854%)
49.610 +0.420 (+0.854%) | 2025/03 - 三個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -0.578 | -9.505 | 0.932 | 8.278 | 19.195 |
| 總資產報酬率 ROA (%) | -0.419 | -6.903 | 0.664 | 5.606 | 11.486 |
| 投入資產回報率 ROIC (%) | -0.497 | -8.181 | 0.776 | 6.451 | 13.701 | 邊際利潤分析 |
| 銷售毛利率 (%) | 43.545 | 41.472 | 49.903 | 52.273 | 58.094 |
| 營業利潤率 (%) | -9.849 | -22.622 | 3.463 | 15.424 | 26.941 |
| 息稅前利潤/營業總收入 (%) | -14.405 | -24.217 | 1.601 | 14.155 | 27.344 |
| 淨利潤/營業總收入 (%) | -8.230 | -23.587 | 2.154 | 11.474 | 21.840 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 53.080 | 44.178 | 206.610 | 115.020 | 96.795 |
| 價值變動淨收益/利潤總額(%) | -14.040 | 8.667 | -28.626 | 38.560 | 14.905 |
| 營業外收支淨額/利潤總額(%) | 4.536 | 1.281 | -30.392 | -8.057 | -4.407 | 償債能力分析 |
| 流動比率 (X) | 2.854 | 2.419 | 2.406 | 2.471 | 3.261 |
| 速動比率 (X) | 2.617 | 2.208 | 2.223 | 2.290 | 3.002 |
| 資產負債率 (%) | 26.678 | 26.077 | 26.511 | 28.945 | 33.764 |
| 帶息債務/全部投入資本 (%) | 14.932 | 11.175 | 14.786 | 16.161 | 19.847 |
| 股東權益/帶息債務 (%) | 563.270 | 787.159 | 570.761 | 508.284 | 372.023 |
| 股東權益/負債合計 (%) | 270.841 | 279.296 | 273.186 | 242.000 | 193.619 |
| 利息保障倍數 (X) | 3.523 | 18.603 | -1.518 | -118.561 | 17.745 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 224.618 | 144.749 | 151.335 | 87.481 | 73.815 |
| 存貨周轉天數 (天) | 139.281 | 95.741 | 109.041 | 85.318 | 119.826 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 11/07/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
